4 ms·

Technology won't fix the issues described in the article, which include scam, african countries not receiving antivenom designed for local snakes, shortages, de

• noah_buddy 2y ago
  Maybe, maybe not. Cheapening costs can improve access, especially if it’s possible to perform a new cheap technique more widely.
• marcosdumay 2y ago
  It most likely will. A big reason why the antivenon for those snakes is rare is because one needs to keep a population of the snakes to produce them. If you don't need the snakes anymore, just the minimum amount countries have on hand for dealing with exotic fauna is enough to justify manufacturing them, and once you are manufacturing them, there's no reason not to do a larger batch and export some.
  • krisoft 2y ago
    I don’t understand what you are saying. Part of the problem is that the african country is buying snake venom specific to snakes in india. This is a problem which is not going to be solved by someone manufacturing a larger batch of snake venom and exporting some. In fact it is caused by that practice at least in part.
    • marcosdumay 2y ago
      Nobody is going to make antivenom for their snakes is large amounts because doing that would risk introducing their snakes on the local fauna. But if you optimize it for full in-vitro manufacturing, then anybody will be able to make it. And there's plenty of demand for somebody to do it, because lots of countries want small amounts of it.
• squigz 2y ago
  Why wouldn't it? > scam Probably not completely, but making the venom more accessible and affordable means less people are likely to fall for it and thus less people are likely to run a scam for it > african countries not receiving antivenom designed for local snakes A more abundant antivenom would mean more can be shipped to wherever it's needed most. > shortages, delay to get to treatment centers, and expensive products. Again, more abundance = easier to get, cheaper to make, etc.